Aging potentiates Aβ-induced depletion of SNAP-25 in mouse hippocampus

Brain Research

Volumn 982, Issue 2, 2003, Pages 219-227

  Chauhan, Neelima B ^a,c,d   Lichtor, Terry ^e   Siegel, George J ^a,b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e RUSH UNIVERSITY   (United States)

Author keywords

Aging; Alzheimer's disease; Dentate gyrus; Glial fibrillary acidic protein; SNAP 25; Supragranular layer

Indexed keywords

AMYLOID BETA PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; MEMBRANE PROTEIN; NERVE PROTEIN; SNAP25 PROTEIN, MOUSE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; HIPPOCAMPAL FIMBRIA; HIPPOCAMPUS; INJECTION; MALE; MOUSE; NEUROPIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; TISSUE SECTION; WILD TYPE; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; TIME;

AGING; AMYLOID BETA-PROTEIN; ANIMALS; HIPPOCAMPUS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; TIME FACTORS;

EID: 0142102406     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)03011-7     Document Type: Article

References (40)

1. Amaral D.G., Witter M.P. Hippocampal formation. Paxinos G. The Rat Nervous System. 2nd Edition: 1995;443-493 Academic Press, New York.
2. Bhatnagar M., Cintra A., Chadi G., Lindberg J., Oitzl M., De Kloet E.R., Moller A., Agnati L.F., Fuxe K. Neurochemical changes in the hippocampus of the brown Norway rat during aging. Neurobiol Aging. 18:(3):1997;319-327.
3. Canning D.R., McKeon R.J., DeWitt D.A., Perry G., Wujek J.R., Frederickson R.C., Silver J. Beta-amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. Exp. Neurol. 124:(2):1993;289-298.
4. Chauhan N.B., Siegel G.J. Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody. J. Neurosci. Res. 69:(1):2002;10-23.
5. Dugar A., Patanow C., O'Callaghan J.P., Lakoski J.M. Immunohistochemical localization and quantification of glial fibrillary acidic protein and synaptosomal-associated protein (mol. wt 25000) in the ageing hippocampus following administration of 5,7-dihydroxytryptamine. Neuroscience. 85:(1):1998;123-133.
6. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 1997;Academic Press, San Diego.
7. Geinisman Y., de Toledo-Morrell L., Morrell F. Aged rats need a preserved complement of perforated axospinous synapses per hippocampal neuron to maintain good spatial memory. Brain Res. 398:(2):1986;266-275.
8. Geinisman Y., de Toledo-Morrell L., Morrell F., Persina I.S., Rossi M. Age-related loss of axospinous synapses formed by two afferent systems in the rat dentate gyrus as revealed by the unbiased stereological dissector technique. Hippocampus. 2:(4):1992;437-444.
9. Giannakopoulous P., Gold G., Michel J.P., Bouras C. Cellular vulnerability in brain aging and Alzheimer's disease. Clinical correlates and molecular background. Ann. Med. Intern. (Paris). 149:1998;187-191.
10. Golde T.E. Alzheimer's disease therapy: Can the amyloid cascade be halted? Neurodegeneration. 111:2003;11-18.
11. Goss J.R., Morgan D.G. Enhanced glial fibrillary acidic protein RNA response to fornix transection in aged mice. J. Neurochem. 64:(3):1995; 1351-1360.
12. Greber S., Lubec G., Cairns N., Fountoulakis M. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease. Electrophoresis. 20:1999;928-934.
13. Hess E.J., Collins K.A., Wilson M.C. Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation. J. Neurosci. 16:1996;3104-3111.
14. Higuchi M., Lee V.M., Trojanowski J.Q. Tau and axonopathy in neurodegenerative disorders. Neuromol. Med. 2:(2):2002;131-150.
15. Kandel E.R. The molecular biology of memory storage: A dialogue between genes and synapses. Science. 294:(5544):2001;1030-1038.
16. Long J.M., Kalehua A.N., Muth N.J., Calhoun M.E., Jucker M., Hengemihle J.M., Ingram D.K., Mouton P.R. Stereological analysis of astrocyte and microglia in aging mouse hippocampus. Neurobiol. Aging. 19:(5):1998;497-503.
17. Minger S.L., Honer W.G., Esiri M.M., McDonald B., Keene J., Nicoll J.A., Carter J., Hope T., Francis P.T. Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60:2001;929-936.
18. Morgan T.E., Xie Z., Goldsmith S., Yoshida T., Lanzrein A.S., Stone D., Rozovsky I., Perry G., Smith M.A., Finch C.E. The mosaic of brain glial hyperactivity during normal ageing and its attenuation by food restriction. Neuroscience. 89:(3):1999;687-699.
19. Morrison J.H., Hof P.R. Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease. Prog. Brain Res. 136:2002;467-486.
20. Mukaetova-Ladinska E.B., Garcia-Siera F., Hurt J., Gertz H.J., Xuereb J.H., Hills R., Brayne C., Huppert F.A., Paykel E.S., McGee M., Jakes R., Honer W.G., Harrington C.R., Wischik C.M. Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. Am. J. Pathol. 157:2000;623-636.
21. Nicolle M.M., Gallagher M., McKinney M. No loss of synaptic proteins in the hippocampus of aged, behaviorally impaired rats. Neurobiol. Aging. 20:1999;343-348.
22. Power J.M., Wu W.W., Sametsky E., Oh M.M., Disterhoft J.F. Age-related enhancement of the slow outward calcium-activated potassium current in hippocampal CA1 pyramidal neurons in vitro. J. Neurosci. 22:2002;7234-7243.
23. Price J.L., Ko A.I., Wade M.J., Tsou S.K., McKeel D.W., Morris J.C. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch. Neurol. 58:2001;1395-1402.
24. Rapp P.R., Gallagher M. Preserved neuron number in the hippocampus of aged rats with spatial learning deficits. Proc. Natl. Acad. Sci. USA. 93:(18):1996;9926-9930.
25. Rasmussen T., Schliemann T., Sorensen J.C., Zimmer J., West M.J. Memory impaired aged rats: no loss of principal hippocampal and subicular neurons. Neurobiol. Aging. 17:(1):1996;143-147.
26. Samuel W., Masliah E., Brush D.E., Garcia-Munoz M., Patino P., Young S.J., Groves P.M. Lesions in the dentate hilum and CA2/CA3 regions of the rat hippocampus produce cognitive deficits that correlate with site-specific glial activation. Neurobiol. Learn. Mem. 68:(2):1997;103-116.
27. Scheff S.W., Sparks D.L., Price D.A. Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease. Dementia. 7:(4):1996;226-232.
28. Scheff S.W., Price D.A. Synaptic density in the inner molecular layer of the hippocampal dentate gyrus in Alzheimer disease. J. Neuropathol. Exp. Neurol. 57:1998;1146-1153.
29. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science. 298:2002;789-791.
30. Shimada A., Kuwamura M., Awakura T., Umemura T., Itakura C. An immunohistochemical and ultrastructural study on age-related astrocytic gliosis in the central nervous system of dogs. J. Vet. Med. Sci. 54:(1):1992;29-36.
31. Shimohama S., Kamiya S., Taniguchi T., Akagawa K., Kimura J. Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease. Biochem. Biophys. Res. Commun. 236:1997;239-242.
32. Shimohama S., Fujimoto S., Sumida Y., Akagawa K., Shirao T., Matsuoka Y., Taniguchi T. Differential expression of rat brain synaptic proteins in development and aging. Biochem. Biophys. Res. Commun. 251:1998;394-398.
33. Sugaya K., Chouinard M., Greene R., Robbins M., Personett D., Kent C., Gallagher M., McKinney M. Molecular indices of neuronal and glial plasticity in the hippocampal formation in a rodent model of age-induced spatial learning impairment. J. Neurosci. 16:(10):1996;3427-3443.
34. Sze C.I., Bi H., Kleinschmidt-DeMasters B.K., Filley C.M., Martin L.J. Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains. J. Neurol. Sci. 175:2000;81-90.
35. Tamamaki N. Development of afferent fiber lamination in the infrapyramidal blade of the rat dentate gyrus. J. Comp. Neurol. 411:(2):1999;257-266.
36. Washbourne P., Thompson P.M., Carta M., Costa E.T., Mathews J.R., Lopez-Bendito G., Molnar Z., Becher M.W., Valenzuela C.F., Partridge L.D., Wilson M.C. Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis. Nat. Neurosci. 5:2002;19-26.
37. Weitzdoerfer R., Dierssen M., Fountoulakis M., Lubec G. Fetal life in Down syndrome starts with normal neuronal density but impaired dendritic spines and synaptosomal structure. J. Neural Transm. Suppl. 61:2001;59-70.
38. Wilson M.C., Mehta P.P., Hess E.J. SNAP-25, enSNAREd in neurotransmission and regulation of behaviour. Biochem. Soc. Trans. 24:1996;670-676.
39. Wu W.W., Oh M.M., Disterhoft J.F. Age-related biophysical alterations of hippocampal pyramidal neurons: implications for learning and memory. Ageing Res. Rev. 1:2002;181-207.
40. Yoo B.C., Cairns N., Fountoulakis M., Lubec G. Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin I in brain of patients with Down syndrome and Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 12:2001;219-225.